Synjardy (empagliflozin/metformin)

pCPA File Number: 20959
Negotiation Status:
Concluded with an LOI
Indication(s):
Diabetes Mellitus, Type 2
Sponsor/Manufacturer:
Boehringer Ingelheim (Canada) Ltd.
CDA-AMC Project Number:
SR0489-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: